论文信息 - Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. - 字舞流文

Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.

L. Adams | G. Jeffrey | A. Mitchell | B. de Boer | R. Howman | Damian J Harding | G. MacQuillan

[1] S. Marciano,et al. Imatinib-induced fatal acute liver failure. , 2007, World journal of gastroenterology.

[2] Y. Mun,et al. Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia , 2007, Acta Haematologica.

[3] B. Portmann,et al. Imatinib mesylate as a cause of acute liver failure , 2006, American journal of hematology.

[4] N. Lin,et al. Fatal hepatic necrosis following imatinib mesylate therapy. , 2003, Blood.

[5] P. Cony-Makhoul,et al. Histological features of acute hepatitis after imatinib mesylate treatment , 2003, Leukemia.

[6] R. Pazdur,et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7] M. López,et al. Supervivencia tras trasplante hepático por fallo hepático agudo debido a imatinib: a propósito de un caso , 2012 .

[8] M. Boccadoro,et al. Corticosteroids can reverse severe imatinib-induced hepatotoxicity. , 2006, Haematologica.

[9] S. Geller,et al. Imatinib (Gleevec)-induced hepatotoxicity. , 2005, Journal of clinical gastroenterology.